Jyothy Labs raises buyback price to ₹240 per share

Jyothy Labs Limited (NSE: JYOTHYLAB) has increased its buyback price from ₹215 to ₹240 per share, while reducing the maximum shares to 61.25 lakh. The total buyback allocation remains approximately ₹147 crore, representing 1.67% of paid-up equity capital. This is positive for eligible shareholders. The revised price is 11.63% higher than the original offer and approximately 18.3% above the November 9 closing price of ₹202.85. However, the buyback does not improve the company's operating business. FY26 net profit declined 10.2% to ₹333 crore, while September 2026 quarterly operating profit fell to ₹19 crore. The financial benefit will primarily come from the reduction in outstanding shares and potential EPS accretion of approximately 1.7%, assuming the entire buyback is completed. The record date is November 11, 2026. Promoters have indicated that they will not participate. The final acceptance ratio remains important for shareholders considering the tender offer. What investors may be missing is that the buyback is happening alongside weakening operating profitability. A sustainable recovery in margins is more important for long-term valuation than this one-time capital return. What to watch: Recovery in operating margins over the next two quarters. Actual shares accepted under the buyback. Operating cash flow and free cash flow after the capital return. Final stance: HOLD.